Tyrosine kinase inhibitor (TKI) plus PD-1 blockade in TKI-responsive MSS/pMMR metastatic colorectal adenocarcinoma (mCRC): Updated results of TRAP study-MedSci.cn

Tyrosine kinase inhibitor (TKI) plus PD-1 blockade in TKI-responsive MSS/pMMR metastatic colorectal adenocarcinoma (mCRC): Updated results of TRAP study

Zhang, J; Dong, Q; Wang, Y; Diao, Y; Cui, X; Man, L; Zhang, Y; Wu, T; Chen, T; Dong, Y; Huang, Y; Wang, S

ANNALS OF ONCOLOGY, 2023; 34 (): S1508

科室
- - 订阅+
  - 更多科室
工具
服务